Cargando…
Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction
We previously reported that S-propargyl-cysteine (SPRC) exerts cardioprotective effects by elevating H(2)S levels via the CSE/H(2)S pathway. In the present study, we investigated the cardioprotective effects and pharmacokinetic properties of a controlled release formulation of SPRC (CR-SPRC) in an i...
Autores principales: | Tran, Ba Hieu, Huang, Chengrong, Zhang, Qiuyan, Liu, Xu, Lin, Shizhou, Liu, Hongrui, Wang, Shujun, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613708/ https://www.ncbi.nlm.nih.gov/pubmed/26182378 http://dx.doi.org/10.1042/BSR20140185 |
Ejemplares similares
-
Cardioprotective Effects of a Novel Hydrogen Sulfide Agent–Controlled Release Formulation of S-Propargyl-Cysteine on Heart Failure Rats and Molecular Mechanisms
por: Huang, Chengrong, et al.
Publicado: (2013) -
The Cardioprotective Actions of Hydrogen Sulfide in Acute Myocardial Infarction and Heart Failure
por: Polhemus, David J., et al.
Publicado: (2014) -
Design, Synthesis,
and Cardioprotective Effects of N-Mercapto-Based
Hydrogen Sulfide Donors
por: Zhao, Yu, et al.
Publicado: (2015) -
The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential
por: Shen, Yaqi, et al.
Publicado: (2015) -
Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
por: Zaorska, Ewelina, et al.
Publicado: (2020)